TRXC INVESTOR ALERT: The Law Offices of Vincent Wong Reminds Investors of a Class Action Involving
TransEnterix, Inc. and a Lead Plaintiff Deadline of August 1, 2016
The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the USDC for the Eastern District of
North Carolina on behalf of investors who purchased TransEnterix, Inc. (NYSE MKT: TRXC) securities between February 10, 2016 and
May 10, 2016.
Click here to learn about the case: http://www.wongesq.com/pslra/transenterix. There is no cost or obligation to you.
The complaint alleges that throughout the Class Period, defendants made false and/or misleading statements and/or failed to
disclose that (a) there were deficiencies within the Company’s 510(k) application to the Food and Drug Administration which
undermined the likelihood that the SurgiBot System would receive FDA clearance; (b) that as a result of these deficiencies,
TransEnterix would be unable to commercialize the SurgiBot in 2016; and (c) consequently, the Company’s ability to obtain approval
for and commercialize its other robotic surgery platforms in the U.S. would be impaired.
If you suffered a loss in TransEnterix you have until August 1, 2016 to request that the Court appoint you as lead plaintiff.
Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff. To obtain additional information, contact
Vincent Wong, Esq. either via email vw@wongesq.com, by telephone at
212.425.1140, or visit http://www.wongesq.com/pslra/transenterix.
Vincent Wong, Esq. is an experienced attorney that has represented investors in securities litigations involving financial fraud
and violations of shareholder rights. Attorney advertising. Prior results do not guarantee similar outcomes.
The Law Offices of Vincent Wong
Vincent Wong, Esq., 212.425.1140
Fax. 866.699.3880
vw@wongesq.com
View source version on businesswire.com: http://www.businesswire.com/news/home/20160705005775/en/